Abstract:Abnormal respiratory chemosensitivity is implicated in recurrent apnea syndromes, with the peripheral chemoreceptors, the carotid bodies, playing a particularly important role. Previous work suggests that supraphysiological concentrations of the endocannabinoid endovanilloid and TASK channel blocker anandamide (ANA) excite carotid bodies, but the mechanism(s) and physiological significance are unknown. Given that carotid body output is temperature-sensitive, we hypothesized that ANA stimulates carotid body chemosensory afferents via temperature-sensitive vanilloid (TRPV1) receptors. To test this hypothesis, we used the dual-perfused in situ rat preparation to confirm that independent perfusion of carotid arteries with supraphysiological concentrations of ANA strongly excites carotid sinus nerve afferents and that this activity is sufficient to increase phrenic activity. Next, using ex vivo carotid body preparations, we demonstrate that these effects are mediated by TRPV1 receptors, not CB1 receptors or TASK channels: in CB1-null mouse preparations, ANA increased afferent activity across all levels of Po(2), whereas in TRPV1-null mouse preparations, the stimulatory effect of ANA was absent. In rat ex vivo preparations, ANA's stimulatory effects were mimicked by olvanil, a nonpungent TRPV1 agonist, and suppressed by the TRPV1 antagonist AMG-9810. The specific CB1 agonist oleamide had no effect. Physiological levels of ANA had no effect alone but increased sensitivity to mild hyperthermia. AMG-9810 blocked ANA's effect on the temperature response. Immunolabeling and RT-PCR demonstrated that TRPV1 receptors are not expressed in carotid body glomus cells but reside in petrosal sensory afferents. Together, these results suggest that ANA plays a physiological role in augmenting afferent responses to mild hyperthermia by activating TRPV1 receptors on petrosal afferents.

Immunohistochemical distribution of cannabinoid receptor type 1 (CB1) and type 2 (CB2) in the rat carotid body

Distribution and morphology of serotonin transporter‐immunoreactive type I cells in the rat carotid body

Carotid body plastic behavior: evidence for D2–H3 receptor–receptor interactions

Inhibitory effects of NO on carotid body: contribution of neural and endothelial nitric oxide synthase isoforms

Neurons synthesizing nitric oxide innervate the mammalian carotid body

Mechanisms of Carotid Body Inhibition

General Morphology of the Mammalian Carotid Body

Strong expression of interleukin-1 receptor type I in the rat carotid body.

Localization and actions of nitric oxide in the cat carotid body

Anandamide modulates carotid sinus nerve afferent activity via TRPV1 receptors increasing responses to heat

Regulation of hypoxia-inducible factor-α isoforms and redox state by carotid body neural activity in rats

Nitric oxide in the sensory function of the carotid body

The carotid body detects circulating tumor necrosis factor-alpha to activate a sympathetic anti-inflammatory reflex

IL-1beta Inhibits IK and Increases [ca2+]i in the Carotid Body Glomus Cells and Increases Carotid Sinus Nerve Firings in the Rat.

Carotid body chemoreception in the absence and presence of CO2-HCO3-

Recent advances in understanding the physiology of hypoxic sensing by the carotid body

THE EFFECT OF IL-1β ON EXPERIMENTAL ACUTE HYPOXIA-INDUCED FIRING OF RAT CAROTID SINUS NERVE

Dual effects of nitric oxide on cat carotid body chemoreception

CO reveals dual mechanisms of O2 chemoreception in the cat carotid body

Actomyosin-mediated Inhibition of Synaptic Vesicle Release under CB1R Activation.

Perspectives in carotid body research